Mauna Kea Technologies
  • Physicians
    • Overview
    • Cellvizio system
    • Education
    • Reimbursement
    • GastroEnterology
    • Barrett’s Esophagus
    • Pancreatic Cysts
    • Gastric Disease
    • Inflammatory Bowel Diseases
    • Irritable Bowel Syndrome
    • Bilio-Pancreatic Strictures
    • Colorectal Lesions
    • Pulmonology
    • Lung Nodules
    • Covid-19
    • Urology
  • Investors
  • About us
    • Our story
    • Team
    • Board of Directors
    • Leadership
    • Join Us
    • Press Coverage
    • Commercial Network
  • News & events
  • US
  • INT
  • FR
Contact

News & Events

MKT Card.png
NEWS - Cellvizio
Jul 25, 2024

Mauna Kea Technologies Announces its Sales and Achievements For the Second Quarter 2024

Discover
CellTolerance News Card.png
NEWS - Cellvizio
Jun 26, 2024

Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances

Discover
PancCyst News and Event.png
NEWS - Cellvizio
Jun 13, 2024

Mauna Kea Technologies Reports New Evidence Highly Supportive of the Use of Cellvizio for Diagnosing Pancreatic Cysts Presented at DDW 2024

Discover
MKT Card.png
NEWS - Cellvizio
Jun 7, 2024

Mauna Kea Technologies announces results of its Combined General Meeting of June 6, 2024

Discover
MKT Card.png
NEWS - Cellvizio
Jun 6, 2024

Mauna Kea Technologies Announces Joint Venture in China Obtained Class II Medical Device Business License

Discover
MKT Card.png
NEWS - Cellvizio
May 30, 2024

Mauna Kea Technologies Winner of “Best New Technology Solution – Oncology” MedTech Breakthrough Award

Discover
See more
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
  • Legal notice
  • Join Us
  • Contact us
  • Cellvizio.net
  • DiagnosingBarretts.org
  • DiagnosingPancreaticCysts.org
Mauna Kea Technologies